Document is current
Any future updates will be listed below
-
Authors
Rappaport, Amy R.
Hong, Sue-Jean
Scallan, Ciaran D.
Gitlin, Leonid
Akoopie, Arvin
Boucher, Gregory R.
Egorova, Milana https://orcid.org/0000-0002-9917-091X
Espinosa, J. Aaron https://orcid.org/0000-0002-7950-4927
Fidanza, Mario
Kachura, Melissa A.
Shen, Annie
Sivko, Gloria
Van Abbema, Anne
Veres, Robert L. https://orcid.org/0000-0003-1234-4815
Jooss, Karin
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 12 November 2021
Accepted: 27 May 2022
First Online: 7 June 2022
Competing interests
: A.R.R., S.J.H., C.D.S., L.G., A.A., G.R.B., M.E., J.A.E., M.F., M.A.K., A.S., A.V.A., R.L.V., and K.J. are stockholders and either current or previous employees at Gritstone Bio, Inc. and may be listed as co-inventors on various pending patent applications related to the vaccine platform presented in this study. The remaining authors declare no competing interests.
